Status:
UNKNOWN
Optimization of the Management of COVID-19 Through Tailored Recommendations to the Citizens
Lead Sponsor:
Laval University
Collaborating Sponsors:
Réseau-1 Québec
Réseau de recherche en santé des populations du Québec
Conditions:
COVID19
Tailored Recommendations
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
People with chronic diseases including atherosclerotic heart disease, high blood pressure and diabetes are considered as a group with a high vulnerability. The COVID-19 pandemic ranging the world is r...
Detailed Description
The COVID-19 pandemic is raging in the world, including Quebec. As of May 22, 2020, more than 46,141 cases have been identified in Quebec, including 3,865 deaths. The virus causes heterogeneous clinic...
Eligibility Criteria
Inclusion
- 18 years old
- Living in Canada
- Able to give an informed consent
Exclusion
- none
Key Trial Info
Start Date :
November 18 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 18 2021
Estimated Enrollment :
1200 Patients enrolled
Trial Details
Trial ID
NCT04699851
Start Date
November 18 2020
End Date
May 18 2021
Last Update
January 8 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Laval University
Québec, Canada, g1v0a6